Clinical associations of quarterly Patient Health Questionnaire‐9 depression screening results in adolescents with type 1 diabetes

2020 ◽  
Vol 21 (5) ◽  
pp. 871-877
Author(s):  
Peter Wolfgram ◽  
Liyun Zhang ◽  
Pippa Simpson ◽  
Rosanna Fiallo‐Scharer
Keyword(s):  
Type 1 Diabetes ◽  
Depression Screening ◽  
Patient Health Questionnaire ◽  
Health Questionnaire ◽  
Patient Health ◽  
Clinical Associations

scholarly journals A retrospective multisite examination of depression screening practices, scores, and correlates in pediatric diabetes care

2019 ◽  
Author(s):  
Shelagh A Mulvaney ◽  
Constance A Mara ◽  
Jessica C Kichler ◽  
Shideh Majidi ◽  
Kimberly A Driscoll ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Depressive Symptoms ◽  
Psychometric Properties ◽  
Mental Health Treatment ◽  
Clinical Care ◽  
Patient Characteristics ◽  
Patient Health Questionnaire ◽  
Health Questionnaire ◽  
Patient Health

Abstract Psychosocial guidelines recommend routine screening of depressive symptoms in adolescents and young adults (AYA) with diabetes. Best practices for screening in routine care and patient characteristics associated with depressive symptoms require further investigation. The purpose of this study was to examine psychometric properties of the Patient Health Questionnaire (PHQ-2 and PHQ-9); document rates of depressive symptoms and related clinical actions; and evaluate associations with patient characteristics. The Patient Health Questionnaire (PHQ-2 or PHQ-9) was administered at five pediatric academic medical centers with 2,138 youth with type 1 diabetes. Screening was part of routine clinical care; retrospective data from electronic health records were collected for the first screening date as well as 12 months prior. The PHQ demonstrated good psychometric properties. Evaluation of item-level PHQ-9 data identified 5.0% of AYA with at least moderate depressive symptoms who would not have been flagged for further screening using the PHQ-2 only. On the PHQ-9, 10.0% of AYA with type 1 diabetes endorsed elevated depressive symptoms and 7.0% endorsed thoughts of self-harm. Patients with moderate or greater depressive symptoms had a 43.9% documented referral rate for mental health treatment. Higher BMI, older age, public insurance, shorter diabetes duration, higher HbA1C, and a diabetic ketoacidosis (DKA) event in the past year were associated with depressive symptoms. The PHQ-9 identified AYA with elevated depressive symptoms that would not have been identified using the PHQ-2. Depressive symptoms were associated with negative diabetes indicators. To improve referral rates, standardized methods for provision and documentation of referrals are needed.

Glycemic outcomes related to depression in adults with type 1 diabetes

2019 ◽  
pp. 135910531987729 ◽  
Author(s):  
Ifeoma Egbuonu ◽  
Paula M Trief ◽  
Cheryl Roe ◽  
Ruth S Weinstock
Keyword(s):  
Type 1 Diabetes ◽  
Blood Glucose ◽  
Blood Glucose Control ◽  
Blood Glucose Monitoring ◽  
Patient Health Questionnaire ◽  
Health Questionnaire ◽  
Depressed Group ◽  
Patient Health ◽  
Glycemic Outcomes

Glycemic outcomes of adults with type 1 diabetes may be affected by depression. Our aim was to compare outcomes of “depressed” (Patient Health Questionnaire-9 ⩾ 10, N = 83) to “not-depressed” matched control (Patient Health Questionnaire-2 < 3, N = 166) adults with type 1 diabetes with objective measures. The depressed group had poorer blood glucose control and, for those with glucose meter downloads, fewer glucose tests/day. The groups did not differ on glucose variability or episodes of hypoglycemia. Depression in adults with type 1 diabetes is associated with poorer glycemic control and less blood glucose monitoring. Future research should examine whether treatment of depression results in better self-care and glycemic outcomes.

Glycemic outcomes related to depression in adults with type 1 diabetes

2021 ◽  
Vol 26 (6) ◽  
pp. 786-794
Author(s):  
Ifeoma Egbuonu ◽  
Paula M Trief ◽  
Cheryl Roe ◽  
Ruth S Weinstock
Keyword(s):  
Type 1 Diabetes ◽  
Blood Glucose ◽  
Blood Glucose Control ◽  
Blood Glucose Monitoring ◽  
Patient Health Questionnaire ◽  
Health Questionnaire ◽  
Depressed Group ◽  
Patient Health ◽  
Glycemic Outcomes

Glycemic outcomes of adults with type 1 diabetes may be affected by depression. Our aim was to compare outcomes of “depressed” (Patient Health Questionnaire-9 ⩾ 10, N = 83) to “not-depressed” matched control (Patient Health Questionnaire-2 < 3, N = 166) adults with type 1 diabetes with objective measures. The depressed group had poorer blood glucose control and, for those with glucose meter downloads, fewer glucose tests/day. The groups did not differ on glucose variability or episodes of hypoglycemia. Depression in adults with type 1 diabetes is associated with poorer glycemic control and less blood glucose monitoring. Future research should examine whether treatment of depression results in better self-care and glycemic outcomes.

Validation of Patient Health Questionnaire for depression screening among primary care patients in Taiwan

2011 ◽  
Vol 52 (1) ◽  
pp. 96-101 ◽  
Author(s):  
Shen-Ing Liu ◽  
Zai-Ting Yeh ◽  
Hui-Chun Huang ◽  
Fang-Ju Sun ◽  
Jin-Jin Tjung ◽  
...  
Keyword(s):  
Primary Care ◽  
Depression Screening ◽  
Patient Health Questionnaire ◽  
Health Questionnaire ◽  
Patient Health ◽  
Primary Care Patients

Depression Screening: Utility of the Patient Health Questionnaire in Patients With Acute Coronary Syndrome

2013 ◽  
Vol 22 (1) ◽  
pp. 12-19 ◽  
Author(s):  
Anthony W. McGuire ◽  
Jo-Ann Eastwood ◽  
Aurelia Macabasco-O'Connell ◽  
Ron D. Hays ◽  
Lynn V. Doering
Keyword(s):  
Acute Coronary Syndrome ◽  
Clinical Decision Making ◽  
Area Under The Curve ◽  
Heart Association ◽  
Depression Screening ◽  
Patient Health Questionnaire ◽  
Youden Index ◽  
Health Questionnaire ◽  
Coronary Syndrome ◽  
Patient Health

BackgroundDepression screening in cardiac patients has been recommended by the American Heart Association, but the best approach remains unclear.ObjectivesTo evaluate nurse-administered versions of the Patient Health Questionnaire for depression screening in patients hospitalized for acute coronary syndrome.MethodsStaff nurses in an urban cardiac care unit administered versions 2, 9, and 10 of the questionnaire to 100 patients with acute coronary syndrome. The Depression Interview and Structured Hamilton was administered by advanced practice nurses blinded to the results of the Patient Health Questionnaire. With the results of the Depression Interview and Structured Hamilton as a criterion, receiver operating characteristic analyses were done for each version of the Patient Health Questionnaire. The Delong method was used for pairwise comparisons. Cutoff scores balancing false-negatives and false-positives were determined by using the Youden Index.ResultsEach version of the questionnaire had excellent area-under- the-curve statistics: 91.2%, 92.6%, and 93.4% for versions 2, 9, and 10, respectively. Differences among the 3 versions were not significant. Each version yielded higher symptom scores in depressed patients than in nondepressed patients: version 2 scores, 3.4 vs 0.6, P = .001; version 9 scores, 13 vs 3.4, P &lt; .001; and version 10 scores, 14.5 vs 3.6, P &lt; .001.ConclusionsFor depression screening in hospitalized patients with acute coronary syndrome, the Patient Health Questionnaire 2 is as accurate as longer versions when administered by nurses. Further study is needed to determine if screening with this tool changes clinical decision making or improves outcomes in these patients.

Validation of the Patient Health Questionnaire (PHQ)-9 for prenatal depression screening

2012 ◽  
Vol 15 (5) ◽  
pp. 367-374 ◽  
Author(s):  
Abbey C. Sidebottom ◽  
Patricia A. Harrison ◽  
Amy Godecker ◽  
Helen Kim
Keyword(s):  
Prenatal Depression ◽  
Depression Screening ◽  
Patient Health Questionnaire ◽  
Health Questionnaire ◽  
Patient Health
Sign in / Sign up

Export Citation Format

Share Document